© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Forte Biosciences, Inc. (FBRX) shows an Average True Range (ATR) of 2.55 and an Enterprise Value of 14.24M. Its average trading volume over the past 3 months is 114.91K, indicating liquidity. These fundamental metrics provide insight into FBRX's underlying financial health and market activity.
Forte Biosciences, Inc. (FBRX) technical indicators as of December 23, 2025: the SMA 20 is 34.97%, SMA 50 at 73.82%, and SMA 200 at 150.56%. The RSI 14 value is 77.93, suggesting its current momentum. These technical analysis signals help assess FBRX's price trends and potential future movements.
Forte Biosciences, Inc. (FBRX) stock performance overview as of December 23, 2025: The 52-week high is $31.27 (currently -1.28% below), and the 52-week low is $4.9 (currently 498.57% above). Over the past year, FBRX's performance is 54.69%, compared to the S&P 500's 10.56% change.
According to market data, Forte Biosciences, Inc. (FBRX) stock's recent performance metrics show that over the last month, FBRX is 56.76%, with a Year-to-Date (YTD) performance of 29.15%. Over the past year, the stock has seen a 54.69% change. These figures summarize FBRX's price movements across various periods, reflecting its historical returns.
According to current financial data, FBRX stock's P/E (TTM) ratio is -9.12, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for FBRX, including P/S (8742.46), P/B (5.61), and P/FCF (-7.45), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.